Literature DB >> 16403644

Nicotinic activity stabilizes convergence of nicotinic and GABAergic synapses on filopodia of hippocampal interneurons.

Wagner M Zago1, Kerri A Massey, Darwin K Berg.   

Abstract

Nicotinic acetylcholine receptors containing alpha7 subunits occupy pre- and postsynaptic sites in the adult hippocampus. We find that embryonic hippocampal slices in culture display the receptors most prominently on interneurons where they form clusters localized in part on filopodia. The receptors often co-distribute specifically with GABAA receptors. In septal-hippocampal co-cultures, the filopodia become co-innervated by cholinergic and GABAergic terminals abutting the receptor clusters. Nicotinic transmission appears to stabilize the cholinergic contacts: pharmacological blockade of the alpha7-containing nicotinic receptors increases the rate of filopodia movement and decreases the incidence of the clusters being adjacent to cholinergic terminals. Immunostaining fresh hippocampal slices from neonatal rat pups confirms that cholinergic and GABAergic terminals contact alpha7-containing nicotinic receptor clusters in vivo, and the clusters appear to include filopodial sites. The results indicate a convergence of nicotinic and GABAergic input at specific sites on developing hippocampal interneurons and suggest that synaptic activity helps stabilize the nicotinic contribution.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16403644     DOI: 10.1016/j.mcn.2005.11.009

Source DB:  PubMed          Journal:  Mol Cell Neurosci        ISSN: 1044-7431            Impact factor:   4.314


  14 in total

Review 1.  Regulation of hippocampal inhibitory circuits by nicotinic acetylcholine receptors.

Authors:  Marilena Griguoli; Enrico Cherubini
Journal:  J Physiol       Date:  2011-11-28       Impact factor: 5.182

2.  PMCA2 via PSD-95 controls calcium signaling by α7-containing nicotinic acetylcholine receptors on aspiny interneurons.

Authors:  David Gómez-Varela; Manuela Schmidt; Jeff Schoellerman; Eric C Peters; Darwin K Berg
Journal:  J Neurosci       Date:  2012-05-16       Impact factor: 6.167

3.  Nicotinic signal transduction machinery.

Authors:  D K Berg; W G Conroy; Z Liu; W M Zago
Journal:  J Mol Neurosci       Date:  2006       Impact factor: 3.444

4.  Reversible inhibition of GABAA receptors by alpha7-containing nicotinic receptors on the vertebrate postsynaptic neurons.

Authors:  Jingming Zhang; Darwin K Berg
Journal:  J Physiol       Date:  2007-01-04       Impact factor: 5.182

5.  BDNF up-regulates alpha7 nicotinic acetylcholine receptor levels on subpopulations of hippocampal interneurons.

Authors:  Kerri A Massey; Wagner M Zago; Darwin K Berg
Journal:  Mol Cell Neurosci       Date:  2006-10-09       Impact factor: 4.314

6.  Early exposure to nicotine during critical periods of brain development: Mechanisms and consequences.

Authors:  Andrew M Smith; Linda P Dwoskin; James R Pauly
Journal:  J Pediatr Biochem       Date:  2010

7.  Effects of ethanol and varenicline on female Sprague-Dawley rats in a third trimester model of fetal alcohol syndrome.

Authors:  Karienn S Montgomery; Eric A Bancroft; Annette S Fincher; Ewelina A Migut; Vincent Provasek; David Murchison; Dustin W DuBois
Journal:  Alcohol       Date:  2018-03-02       Impact factor: 2.405

Review 8.  Acetylcholine as a neuromodulator: cholinergic signaling shapes nervous system function and behavior.

Authors:  Marina R Picciotto; Michael J Higley; Yann S Mineur
Journal:  Neuron       Date:  2012-10-04       Impact factor: 17.173

9.  Altered hippocampal circuit function in C3H alpha7 null mutant heterozygous mice.

Authors:  C E Adams; J C Yonchek; L Zheng; A C Collins; K E Stevens
Journal:  Brain Res       Date:  2007-12-08       Impact factor: 3.252

10.  Cholinergic axons modulate GABAergic signaling among hippocampal interneurons via postsynaptic alpha 7 nicotinic receptors.

Authors:  Nicolas Wanaverbecq; Alexey Semyanov; Ivan Pavlov; Matthew C Walker; Dimitri M Kullmann
Journal:  J Neurosci       Date:  2007-05-23       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.